Your browser doesn't support javascript.
loading
Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjögren's Syndrome.
Sharma, Rohan; Harris, Valerie M; Cavett, Joshua; Kurien, Biji T; Liu, Ke; Koelsch, Kristi A; Fayaaz, Anum; Chaudhari, Kaustubh S; Radfar, Lida; Lewis, David; Stone, Donald U; Kaufman, C Erick; Li, Shibo; Segal, Barbara; Wallace, Daniel J; Weisman, Michael H; Venuturupalli, Swamy; Kelly, Jennifer A; Pons-Estel, Bernardo; Jonsson, Roland; Lu, Xianglan; Gottenberg, Jacques-Eric; Anaya, Juan-Manuel; Cunninghame-Graham, Deborah S; Huang, Andrew J W; Brennan, Michael T; Hughes, Pamela; Alevizos, Ilias; Miceli-Richard, Corinne; Keystone, Edward C; Bykerk, Vivian P; Hirschfield, Gideon; Nordmark, Gunnel; Bucher, Sara Magnusson; Eriksson, Per; Omdal, Roald; Rhodus, Nelson L; Rischmueller, Maureen; Rohrer, Michael; Wahren-Herlenius, Marie; Witte, Torsten; Alarcón-Riquelme, Marta; Mariette, Xavier; Lessard, Christopher J; Harley, John B; Ng, Wan-Fai; Rasmussen, Astrid; Sivils, Kathy L; Scofield, R Hal.
Affiliation
  • Sharma R; Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, and Department of Veterans Affairs Medical Center, Oklahoma City.
  • Harris VM; Oklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma City.
  • Cavett J; Oklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma City.
  • Kurien BT; Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, and Department of Veterans Affairs Medical Center, Oklahoma City.
  • Liu K; Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio.
  • Koelsch KA; Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, and Department of Veterans Affairs Medical Center, Oklahoma City.
  • Fayaaz A; Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma.
  • Chaudhari KS; Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma.
  • Radfar L; University of Oklahoma Health Sciences Center, Oklahoma City.
  • Lewis D; University of Oklahoma Health Sciences Center, Oklahoma City.
  • Stone DU; Johns Hopkins University, Baltimore, Maryland, and King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
  • Kaufman CE; University of Oklahoma Health Sciences Center, Oklahoma City.
  • Li S; University of Oklahoma Health Sciences Center, Oklahoma City.
  • Segal B; University of Minnesota Medical School, Minneapolis.
  • Wallace DJ; Cedars-Sinai Medical Center, Los Angeles, California.
  • Weisman MH; Cedars-Sinai Medical Center, Los Angeles, California.
  • Venuturupalli S; Cedars-Sinai Medical Center, Los Angeles, California.
  • Kelly JA; Oklahoma Medical Research Foundation, Oklahoma City.
  • Pons-Estel B; Sanatorio Parque, Rosario, Argentina.
  • Jonsson R; University of Bergen and Haukeland University Hospital, Bergen, Norway.
  • Lu X; University of Oklahoma Health Sciences Center, Oklahoma City.
  • Gottenberg JE; Strasbourg University, Strasbourg, France.
  • Anaya JM; Universidad del Rosario, Bogota, Colombia.
  • Cunninghame-Graham DS; King's College London, London, UK.
  • Huang AJW; University of Minnesota, Minneapolis.
  • Brennan MT; Carolinas Medical Center, Charlotte, North Carolina.
  • Hughes P; University of Minnesota, Minneapolis.
  • Alevizos I; National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD.
  • Miceli-Richard C; Department of Rheumatology, Université Paris-Sud, AP-HP, INSERM U1012, Le Kremlin-Bicêtre, France.
  • Keystone EC; Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada.
  • Bykerk VP; Hospital for Special Surgery, New York, New York.
  • Hirschfield G; University of Birmingham, Birmingham, UK.
  • Nordmark G; Uppsala University, Uppsala, Sweden.
  • Bucher SM; Örebro University Hospital, Örebro, Sweden.
  • Eriksson P; Linköping University, Linköping, Sweden.
  • Omdal R; Stavanger University Hospital, Stavanger, Norway.
  • Rhodus NL; University of Minnesota, Minneapolis.
  • Rischmueller M; The Queen Elizabeth Hospital, Woodville South, and University of Adelaide, Adelaide, South Australia, Australia.
  • Rohrer M; University of Minnesota, Minneapolis.
  • Wahren-Herlenius M; Karolinska Institutet, Stockholm, Sweden.
  • Witte T; Hannover Medical School, Hannover, Germany.
  • Alarcón-Riquelme M; Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain, and Karolinska Institutet, Stockholm, Sweden.
  • Mariette X; Department of Rheumatology, Université Paris-Sud, AP-HP, INSERM U1012, Le Kremlin-Bicêtre, France.
  • Lessard CJ; Oklahoma Medical Research Foundation, Oklahoma City.
  • Harley JB; Cincinnati Children's Hospital Medical Center, University of Cincinnati, and Ohio Department of Veterans Affairs Medical Center, Cincinnati.
  • Ng WF; Newcastle University, Newcastle upon Tyne, UK.
  • Rasmussen A; Oklahoma Medical Research Foundation, Oklahoma City.
  • Sivils KL; Oklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma City.
  • Scofield RH; Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, and Department of Veterans Affairs Medical Center, Oklahoma City.
Arthritis Rheumatol ; 69(11): 2187-2192, 2017 11.
Article in En | MEDLINE | ID: mdl-28692793
ABSTRACT

OBJECTIVE:

Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE) are related by clinical and serologic manifestations as well as genetic risks. Both diseases are more commonly found in women than in men, at a ratio of ~10 to 1. Common X chromosome aneuploidies, 47,XXY and 47,XXX, are enriched among men and women, respectively, in either disease, suggesting a dose effect on the X chromosome.

METHODS:

We examined cohorts of SS and SLE patients by constructing intensity plots of X chromosome single-nucleotide polymorphism alleles, along with determining the karyotype of selected patients.

RESULTS:

Among ~2,500 women with SLE, we found 3 patients with a triple mosaic, consisting of 45,X/46,XX/47,XXX. Among ~2,100 women with SS, 1 patient had 45,X/46,XX/47,XXX, with a triplication of the distal p arm of the X chromosome in the 47,XXX cells. Neither the triple mosaic nor the partial triplication was found among the controls. In another SS cohort, we found a mother/daughter pair with partial triplication of this same region of the X chromosome. The triple mosaic occurs in ~1 in 25,000-50,000 live female births, while partial triplications are even rarer.

CONCLUSION:

Very rare X chromosome abnormalities are present among patients with either SS or SLE and may inform the location of a gene(s) that mediates an X dose effect, as well as critical cell types in which such an effect is operative.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Sex Chromosome Aberrations / Sjogren's Syndrome / Chromosomes, Human, X / Lupus Erythematosus, Systemic / Mosaicism Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Arthritis Rheumatol Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Sex Chromosome Aberrations / Sjogren's Syndrome / Chromosomes, Human, X / Lupus Erythematosus, Systemic / Mosaicism Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Arthritis Rheumatol Year: 2017 Type: Article